Physician profile
Alexandra Cooper
NPI 1154098259
$7,041.29
in general payments reported to CMS, 2019-2025
20 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $331 · 2022: $1,998 · 2023: $2,626 · 2024: $1,620 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,445 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,444.54 |
| Education | $268.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $954.01 | 2022-2025 | |
| Janssen Biotech, INC. | $893.78 | 2022-2025 | Tremfya, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $734.28 | 2022-2025 | Ilumya, Winlevi |
| Incyte Corporation | $507.44 | 2021-2024 | Opzelura |
| Dermavant Sciences, INC. | $486.53 | 2022-2024 | Vtama |
| Galderma Laboratories, L.P. | $474.91 | 2022-2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $472.13 | 2023-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $435.24 | 2021-2025 | Dupixent, Libtayo |
| Ucb, INC. | $354.89 | 2022-2025 | Bimzelx, Cimzia |
| Leo Pharma INC. | $316.98 | 2022-2023 | Adbry |
| Genzyme Corporation | $271.56 | 2022-2024 | |
| Lilly USA, LLC | $215.63 | 2023-2024 | Taltz, Olumiant |
| Mayne Pharma Commercial LLC | $159.52 | 2023 | |
| Novartis Pharmaceuticals Corporation | $153.67 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $148.12 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $145.07 | 2023-2024 | Zoryve |
| Amgen INC. | $140.87 | 2023-2024 | Otezla |
| Pfizer INC. | $102.24 | 2021-2025 | |
| Medimetriks Pharmaceuticals, INC. | $53.35 | 2023 | Neo-Synalar |
| Epi Health, LLC | $21.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.